Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+. Its lead product...
10 insider purchases on record · latest filing 2025-10-16.
Insiders have also filed 26 sale transactions at STRO.